EMBS Peritoneal Dialysis Fluids
key details
| Value | £10,495,802 |
|---|---|
| Status | complete |
| Category (CPV) | 33690000 |
| Deadline | 17 Jul 2018 |
| Contract start | 17 Aug 2018 |
| Contract end | 14 Jan 2021 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-61208761-5044-4efe-8634-2bff44174972 |
Awards (2)
This procurement was awarded to 2 suppliers. Values shown are per-award; the notice total is £10,495,802.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Baxter Healthcare Ltd shared | £10,495,802 | 5 Sept 2018 | active |
| Fresenius Medical Care UK Ltd shared | £10,495,802 | 5 Sept 2018 | active |
description
Peritoneal Dialysis Fluids - Note: Published for completeness, see description for details. This contract award notice was not published at the time of award. It has been published for transparency purposes to provide a record of existing departmental records, and this contract award predates the launch of this current version of Contracts Finder.
a full list of PD fluids and the related tender documents are published on the Departments tendering system
Please sign up to the Department's tendering system via the below link to be able to register interest and complete your tender submission.
https://dh.bravosolution.co.uk/web/login.html
The Authority owns an Essential Medicines Buffer Stockpile (EMBS), which was first set up in 2009. The purpose of the EMBS is to have medicines that are routinely used in the NHS, available for release into the UK supply chain in the event of pandemic or other health emergency. The current EMBS contract was finalised in November 2015 and runs for 4 years to November 2019.
A clinical review of the current EMBS contract has identified revisions to intravenous (IV) and peritoneal dialysis (PD) fluids for which there are at present no contracts or buffer stocks. Creating a buffer stock for PD fluids is the subject of this procurement.
The Essential Medicines Buffer Stock for PD fluids will operate differently to other national stockpiles in that the suppliers who win the contracts are required to store and rotate the stock through their normal supply chain to prevent it from expiring. All the stock must be held with at least a 12 month expiry date and it must be held within the UK. The Contract will be for a period of up to 17 months with the option to extend a further 12 months at the Authorities discretion.
Additional information:
NOTE: published for completeness, this contract award was not published at time of award and has been published for transparency purposes to provide a record of existing departmental contracts.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 19 Aug 2019 | Award (award) | · | 7adb48d0-96fb-462a-815f-c156e4493427-308828 |
more from Department of Health and Social Care
- DHSC Sinogo claim legal support · £100,000 · 22 Jul 2026
- National Institute for Health and Care Research (NIHR) pre-action letter advice · £80,000 · 22 Jul 2026
- DHSC: ASC: Waves 3 – 5 of the Adult Social Care Workforce Employee Survey · 15 Jul 2026
- Hugh's Report - MH Impact of Life-Threatening Child Illness on Families 2026 · 26 Jun 2026
- Library Mgmt and Enquiry System, E-Archive · £22,578 · 22 Jun 2026
- DHSC: Leeds Maternity Review legal services · £432,000 · 22 Jun 2026
- DHSC:TDD: Technology, Digital and Data (TDD) Operating Model Sprint · £790,000 · 19 Jun 2026
- DHSC: TD: HDRS Corporate technical specialist data services MR · £250,000 · 16 Jun 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Labs Consumables ePunchout 3 · UNIVERSITY OF SOUTHAMPTON · £1,500,000
- Supply of reagents · NEWCASTLE UNIVERSITY · £177,420
- Supply of reagents · NEWCASTLE UNIVERSITY · £37,829
- Supply of reagents · NEWCASTLE UNIVERSITY · £36,485
- Supply of Antibodies · NEWCASTLE UNIVERSITY · £23,108
- Suplly of Reagents · NEWCASTLE UNIVERSITY · £23,212
- Controlled drugs · London Ambulance Service NHS Trust · £154,225
- IonOptix cardiomyocyte fluo-3 calcium and contractility acquisition system. · UNIVERSITY OF NOTTINGHAM (THE) · £67,737
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.